Date: February 26, 2020

Time:
Registration: 5:30 - 6:00pm
Panel discussion: 6:00 - 7:30pm
Cocktail reception to follow

Location:
Waldorf Astoria
Hardenbergstraße 28
Berlin, Germany 10623
View map

Please click here to register.

McDermott Will & Emery is delighted to welcome you to a panel discussion on “Private Equity in Healthcare” and a social reception held in conjunction with the SuperReturn International Conference 2020.

Our speakers will discuss the current “hot areas” for private equity investment in the healthcare space, both in Europe and the US. In addition, they will cover related topics such as government focus on healthcare private equity investments and how that focus is affected by public need, policy initiatives and specific agency attention. Please stay tuned for further developments as we will be announcing additional panellists in coming weeks.

Please join us for a wonderful opportunity to network, socialise and wind down from an engaging and interesting global conference.

Moderator

Dr. Stephan Rau Partner +49 89 12712 322 Email

Speakers

	Sharon Lamb Partner +44 20 7577 6943 Email		David S. Ivill Partner +1 212 547 5698 Email
	Alan MacKay Executive Partner and Founder GHO Capital Partners LLP		Thomas C. Weinmann Managing Partner Astorius

Speaker information:

Sharon Lamb is a partner in McDermott's London office and has been advising private and public health care clients for more than 17 years. Sharon focuses her practice on health care transactions, investments and projects, as well as comprehensive health care regulatory advice.

David S. Ivill is partner-in-charge of the McDermott New York healthcare practice. David has built a strong profile in advising private equity clients active in the healthcare market, both in New York and nationally. David is a highly sought after advisor providing innovative and insightful advice on operational and management issues in the context of complex regulatory healthcare frameworks.

Alan MacKay has been a private equity investor for 30 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. Alan has served on the boards of a number of healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014.

Thomas Weinmann has over 20 years experience the Private Equity sector. Thomas spent almost 13 successful years, nine of which as a partner, at BC Partners. At the end of 2012, he founded Astorius Capital with the goal of making Private Equity accessible to investors. Thomas also provides advice to family-owned companies and acts as an advisor to an established Private Equity fund. In addition to his work in operations, from 2011 to 2015 he was the Honorary Director at the German Association of Private Equity and Venture Capital.

Please click here to register.

[View source.]